S&P 500

5.667,20

0,64%

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

Startseite
Investieren
Aktien
USA
NASDAQ
Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)
Angiotech Pharmaceuticals - Common Shares (MM) (ANPI) News

ANPI

Angiotech Pharmaceuticals - Common Shares (MM) (ANPI)

Angiotech Pharmaceuticals - Common Shares (MM)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ANPI

<< Previous 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
02/06/2005	16h01	PR Newswire (US)	Angiotech broadens Paclitaxel franchise with license to Broncus Technologies for novel treatment of emphysema	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
02/06/2005	00h00	PR Newswire (US)	Angiotech updates 2005 and 2006 financial outlook	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
26/05/2005	10h51	PR Newswire (US)	Angiotech partner announces 400th patient enrolled in study of next-generation TAXUS(R) Liberte(TM) coronary stent system	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
25/05/2005	19h11	PR Newswire (US)	ARRIVE registry supports positive safety profile of TAXUS(R) Express(2)(TM) stent system in diabetic and other patients	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
25/05/2005	13h29	PR Newswire (US)	Trial results support safety for next-generation Taxus(R) Liberte(TM) paclitaxel-eluting stent system	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
25/05/2005	13h05	PR Newswire (US)	TAXUS V sub-population data further support efficacy of TAXUS(R) Express(2)(TM) stent system in diabetic patients	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
24/05/2005	18h40	PR Newswire (US)	Moderate-release TAXUS(R) Express(2)(TM) coronary stent system demonstrates excellent durability in high-risk patients out to tw	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
24/05/2005	18h30	PR Newswire (US)	TAXUS V IVUS results support safety and efficacy in most challenging lesions and highest-risk patients	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
23/05/2005	09h00	PR Newswire (US)	FDA approves 12-month shelf life for TAXUS(R) stent system	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
20/05/2005	17h13	PR Newswire (US)	Angiotech partner to release broad range of clinical trial results on market-leading TAXUS(R) EXPRESS2(TM) coronary stent system	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
17/05/2005	22h04	PR Newswire (US)	Angiotech Pharmaceuticals to participate in 2005 UBS Global Pharmaceuticals Conference	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
12/05/2005	19h17	PR Newswire (US)	Angiotech Pharmaceuticals to participate in Banc of America Health Care Conference 2005	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
04/05/2005	23h00	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. announces results for the quarter ended March 31, 2005	NASDAQ:ANPI
04/05/2005	19h00	PR Newswire (US)	Angiotech announces positive safety data	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
03/05/2005	19h05	PR Newswire (US)	Angiotech partner announces first international trial of a paclitaxel-eluting stent for peripheral artery disease	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
27/04/2005	16h00	PR Newswire (US)	Angiotech to webcast conference call discussing first quarter 2005 financial results	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
26/04/2005	23h05	PR Newswire (US)	Angiotech Pharmaceuticals to participate in Deutsche Bank Conference	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
21/04/2005	00h51	PR Newswire (US)	Angiotech partner announces publication of six TAXUS IV articles in prestigious Journal of American College of CARDIOLOGY	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
14/04/2005	19h49	PR Newswire (US)	Angiotech partner announces FDA approval and launch of Liberte(TM) coronary stent system	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
12/04/2005	18h26	PR Newswire (US)	Angiotech partner announces start of enrollment in groundbreaking clinical trial comparing drug-eluting stents to cardiac surger	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
06/04/2005	18h24	PR Newswire (US)	Angiotech partner receives CE Mark for three large sizes of its market- leading TAXUS(R) Express2(TM) paclitaxel-eluting coronar	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
05/04/2005	16h05	PR Newswire (US)	Angiotech partner first to receive FDA approval allowing immediate MRI exams for its TAXUS(R) Express(2)(TM) paclitaxel-eluting	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
24/03/2005	21h00	PR Newswire (US)	Angiotech Pharmaceuticals to participate in Lehman Brothers Conference	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
23/03/2005	20h52	PR Newswire (US)	First U.S. drug-eluting stent trial to treat peripheral arterial disease enrolls first patient at Stanford University Medical Ce	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
23/03/2005	14h30	PR Newswire (US)	Angiotech and CABG Medical, Inc. enter exclusive license agreement to extend paclitaxel technology into coronary bypass surgery	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
06/03/2005	23h14	PR Newswire (US)	JNJ REALITY Trial fails to meet endpoints	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
06/03/2005	16h20	PR Newswire (US)	TAXUS V demonstrates excellent safety and efficacy results in most challenging lesions and high-risk patients	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
28/02/2005	22h00	PR Newswire (US)	Angiotech Pharmaceuticals, Inc. announces results for the quarter and year ended December 31, 2004	NASDAQ:ANPI
23/02/2005	18h35	PR Newswire (US)	Angiotech partner announces start of enrollment in world's largest drug-eluting stent registry	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)
22/02/2005	14h35	PR Newswire (US)	Angiotech partner announces completion of enrollment in pivotal clinical trial for next-generation paclitaxel-eluting coronary s	NASDAQ:ANPI	Angiotech Pharmaceuticals - Common Shares (MM)